Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Estee Gold Feet Tbk. (EURO) vs Organon Pharma Indonesia Tbk. (SCPI)

Estee Gold Feet Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Estee Gold Feet Tbk. dan Organon Pharma Indonesia Tbk.: Estee Gold Feet Tbk. diperdagangkan di Rp1.400 (kapitalisasi pasar 3,68 T, volume 24 jam 168,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Estee Gold Feet Tbk. jauh lebih besar — sekitar 35,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

EUROSCPI
Kapitalisasi Pasar
3,68 T104,4 M
Volume
168,3 rb
Lot
1,68 rb
Perputaran
233,12 jt
Harga Rata-rata
1.385,12
Nilai Transaksi
233,12 jt
Harga Ekuilibrium Indikatif
1.400
Volume Ekuilibrium Indikatif
71

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EURO
Lihat detail
SCPI
Lihat detail

Tentang Estee Gold Feet Tbk.

PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.

Selengkapnya di halaman EURO

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI